Panel: All adults should get whooping cough shots

February 22, 2012 By MIKE STOBBE , AP Medical Writer in Health

A federal advisory panel wants all U.S. adults to get vaccinated against whooping cough.

The panel voted Wednesday to expand its recommendation to include all those 65 and older who haven't gotten a whooping cough shot as an adult.

Children have been vaccinated against whooping cough since the 1940s, but a vaccine for adolescents and adults was not licensed until 2005.

Since then, the Advisory Committee on Immunization Practices has gradually added groups of adults to its recommendations, including 2010 advice that it be given to elderly people who spend a lot of time around infants.

Wednesday's recommendation means now all adults should get at least one dose.

"They've been moving up to this in ," said Dr. William Schaffner, a Vanderbilt University vaccines expert.

Whooping cough, or , is a highly contagious that in rare cases can be fatal. It leads to severe coughing that causes children to make a distinctive whooping sound as they gasp for breath.

Recommendations from the panel are usually adopted by the government, which sends the guidance out to doctors.

Contributing to the push to vaccinate more adults was a California whooping cough epidemic in 2010 that infected 9,000. Ten babies died after exposure to infected adults or older children.

There's little data on how many elderly people have gotten the vaccine. Only about 8 percent of adults under 65 have been vaccinated, but about 70 percent of adolescents have.

believe whooping cough is underreported in , perhaps because in older people the illness can be hard to distinguish from other coughing ailments.

A goal of the recommendation is to prevent teens and adults from spreading the disease to infants, although there's not good evidence this "herd immunity" approach has worked so far. Vaccination for children is included in a series of shots, beginning at 2 months.

The adult vaccine combines protection against tetanus, and whooping cough. One version of the vaccine, made by GlaxoSmithKline, was licensed for use in the elderly last year. The committee said another version, made by Sanofi Pasteur, can also be given. Both cost about $35 a dose.

The shot is as safe as a regular tetanus booster. Estimates range widely for how effective the vaccine is at preventing in older adults, or how much its protection wanes years afterward.

More information: CDC: http://www.cdc.gov/vaccines/recs/ACIP/

©2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).

Health created 20 hours ago | popularity not rated yet | comments 0 | with audio podcast

Youth who have their first drink during puberty have higher levels of later drinking

Research shows that the earlier the age at which youth take their first alcoholic drink, the greater the risk of developing alcohol problems. Thus, age at first drink (AFD) is generally considered a powerful predictor of ...

Health created May 17, 2013 | popularity not rated yet | comments 0

British MPs concerned about parliamentary boozing

One quarter of British lawmakers believe there is an "unhealthy" drinking culture in the Houses of Parliament, according to a survey published on Friday.

Health created May 17, 2013 | popularity not rated yet | comments 0

Patient openness to research can depend on race and sex of study personnel

Researchers at the University of Cincinnati (UC) have found that the race and sex of study personnel can influence a patient's decision on whether or not to participate in clinical research.

Health created May 17, 2013 | popularity not rated yet | comments 0

Clinical support for patient self-management is rhetoric rather than reality

The processes to allow people to self-manage their own illness are not being used appropriately by health professionals to the benefit of their patients, new research suggests.

Health created May 17, 2013 | popularity not rated yet | comments 0


Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

Research examines new methods for managing digestive health

Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.

New smartphone application improves colonoscopy preparation

The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...

New research identifies practice changes to improve value and quality of GI procedures

There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).

US psychiatry gets makeover in new manual

The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.